Novavax receives a sales rating. It has a Covid vaccine problem, analysts say.
Text size A healthcare professional is preparing a dose of Nuvaxovid vaccine. Jeroen Jumelet / ANP / AFP via Getty Images Novavax the stock fell on Friday after receiving a sales equivalent rating – the first since December 2020 and the only one from Wall Street. Bank of America Securities analyst Alec Stranahan began coverage … Read more